Radiation therapy of breast cancer in the Nahe Breast Center: first results of an analysis in the context of health services research

Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y, Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087–2106

Article  CAS  PubMed  Google Scholar 

Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R, Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378(9804):1707–1716

Article  CAS  PubMed  Google Scholar 

Pötter R, Gnant M, Kwasny W, Tausch C, Handl-Zeller L, Pakisch B, Taucher S, Hammer J, Luschin-Ebengreuth G, Schmid M, Sedlmayer F, Stierer M, Reiner G, Kapp K, Hofbauer F, Rottenfusser A, Pöstlberger S, Haider K, Draxler W, Jakesz R, Austrian Breast and Colorectal Cancer Study Group (2007) Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer. Int J Radiat Oncol Biol Phys 68(2):334–340

Article  PubMed  Google Scholar 

Hughes KS, Schnaper LA, Bellon JR, Cirrincione CT, Berry DA, McCormick B, Muss HB, Smith BL, Hudis CA, Winer EP, Wood WC (2013) Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol 31(19):2382–2387

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM, PRIME II investigators (2015) Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol 16(3):266–273

Article  PubMed  Google Scholar 

Blamey RW, Bates T, Chetty U, Duffy SW, Ellis IO, George D, Mallon E, Mitchell MJ, Monypenny I, Morgan DA, Macmillan RD, Patnick J, Pinder SE (2013) Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. Eur J Cancer 49(10):2294–2302

Article  CAS  PubMed  Google Scholar 

Fyles AW, McCready DR, Manchul LA, Trudeau ME, Merante P, Pintilie M, Weir LM, Olivotto IA (2004) Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351(10):963–970

Article  CAS  PubMed  Google Scholar 

Kauer-Dorner D, Pötter R, Resch A, Handl-Zeller L, Kirchheiner K, Meyer-Schell K, Dörr W (2012) Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial. Radiother Oncol 102(1):96–101

Article  PubMed  Google Scholar 

Sedlmayer F, Sautter-Bihl ML, Budach W, Dunst J, Fastner G, Feyer P, Fietkau R, Haase W, Harms W, Souchon R, Wenz F, Sauer R, Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) (2013) DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Strahlenther Onkol 189(10):825–833

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wei J, Jiang Y, Shao Z (2020) The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype. Breast 51:40–49

Article  PubMed  PubMed Central  Google Scholar 

Guo X‑Y, Sun G‑Y, Wang H‑M, Liu M, Zhang Y‑J, Zhang N, Tang Y, Zhao X‑R, Jing H, Fang H, Wen G, Qi-Shuai G, Wu H‑F, Wang X‑H, Ma C‑Y, Li Y‑X, Cheng J, Shi MS-LW (2022) Effect of postmastectomy radiotherapy on pT1-2N1 breast cancer patients with different molecular subtypes. Breast 61:108–117

Article  PubMed  Google Scholar 

Ursini LA, Nuzzo M, Rosa C, Borgia M, Caravatta L, Di Tommaso M, Trignani M, Di Guglielmo FC, Ausili Cefaro G, Angelucci D, Muzi M, Martino G, Cianchetti E, Grossi S, Tavoletta S, Brocco D, Grassadonia A, Tinari N, Gildetti S, D’Ostilio N, Stuppia L, Porreca A, Di Nicola M, Genovesi D (2022) Whole breast radiotherapy in cN0 early breast cancer patients with pathological sentinel lymph nodes (pN1mic, pN1a) without axillary dissection: preliminary results of the observational LISEN trial. Strahlenther Onkol 198(7):612–621

Article  PubMed  PubMed Central  Google Scholar 

Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM (2023) Breast-conserving surgery with or without irradiation in early breast cancer. N Engl J Med 388:585–594

Article  PubMed  Google Scholar 

Amor BR, Bohli M, Naimi Z, Aissaoui D, Mejri N, Yahyaoui J, Hamdoun A, Kochbati L (2023) Hypofractionated radiotherapy after breast-conserving surgery: Clinical and dosimetric factors predictive of acute skin toxicity. Strahlenther Onkol 199(1):48–54

Article  PubMed  Google Scholar 

Mangesius J, Minasch D, Fink K, Nevinny-Stickel M, Lukas P, Ganswindt U, Seppi T (2023) Systematic risk analysis of radiation pneumonitis in breast cancer: role of cotreatment with chemo-, endocrine, and targeted therapy. Strahlenther Onkol 199(1):67–77

Article  PubMed  Google Scholar 

Comments (0)

No login
gif